INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-15 Cr | ₹3.80 Cr | ₹1.84 Cr | ₹1.93 Cr | ₹1.61 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INNOVA CAPTAB ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-15 Cr |
Mar2023 | ₹3.80 Cr |
Mar2022 | ₹1.84 Cr |
Mar2021 | ₹1.93 Cr |
Mar2020 | ₹1.61 Cr |
How is Deferred Tax Assets / Liabilities of INNOVA CAPTAB Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-15 Cr | Negative | |
Mar2023 | ₹3.80 Cr | 106.91 | |
Mar2022 | ₹1.84 Cr | -4.62 | |
Mar2021 | ₹1.93 Cr | 19.93 | |
Mar2020 | ₹1.61 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,074.5 Cr | 2.9% | 0.6% | 79.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 2.9% |
0.6% |
79.7% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses